 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/26/2026 |
$1.47 |
$1.51 |
$1.26 |
$1.32 |
5.00M | | 02/27/2026 |
$1.30 |
$1.34 |
$1.26 |
$1.31 |
7.00M | | 03/02/2026 |
$1.27 |
$1.30 |
$1.24 |
$1.26 |
3.00M | | 03/03/2026 |
$1.23 |
$1.27 |
$1.21 |
$1.22 |
3.82M | | 03/04/2026 |
$1.23 |
$1.28 |
$1.22 |
$1.25 |
1.92M |
|
|
| Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company. Co. is focused on developing and commercializing therapeutics. Co.'s portfolio and hypoxia-inducible factor (HIF)-based pipeline includes Auryxia (ferric citrate), Vafseo (vadadustat), AKB-9090 and AKB-10108. Auryxia (ferric citrate) is an orally administered medicine approved and marketed in the U.S. for two indications: the control of serum phosphorus levels in adult patients with dialysis dependent chronic kidney disease (DD-CKD), and the treatment of iron deficiency anemia (IDA), in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). | |
|
Akebia Therapeutics (AKBA) has the following price history information. Looking back at AKBA historical stock prices for the last five trading days, on February 26, 2026, AKBA opened at $1.47, traded as high as $1.51 and as low as $1.26, and closed at $1.32. Trading volume was a total of 5.00M shares. On February 27, 2026, AKBA opened at $1.30, traded as high as $1.34 and as low as $1.26, and closed at $1.31. Trading volume was a total of 7.00M shares. On March 02, 2026, AKBA opened at $1.27, traded as high as $1.30 and as low as $1.24, and closed at $1.26. Trading volume was a total of 3.00M shares. On March 03, 2026, AKBA opened at $1.23, traded as high as $1.27 and as low as $1.21, and closed at $1.22. Trading volume was a total of 3.82M shares. On March 04, 2026, AKBA opened at $1.23, traded as high as $1.28 and as low as $1.22, and closed at $1.25. Trading volume was a total of 1.92M shares.
AKBA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Akebia Therapeutics shares, starting with a $10,000 purchase of AKBA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/08/2016 |
|
| End date: |
03/04/2026 |
|
| Start price/share: |
$7.94 |
|
| End price/share: |
$1.25 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-84.26% |
|
| Average Annual Total Return: |
-16.89% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,573.89 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 02/26/2026 | $1.32 | | 02/27/2026 | $1.31 | | 03/02/2026 | $1.26 | | 03/03/2026 | $1.22 | | 03/04/2026 | $1.25 |
|
|
Free AKBA Email Alerts:
